AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology
About AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
BeiGene
2
AVEO Pharmaceuticals, Inc.
1
Stemline Therapeutics, Inc.
1
Clinical Trials at AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology
During the past decade, AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer
2018-07-23
2023-01-03
Completed
136
Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer
2019-05-10
2024-08-01
Active, not recruiting
466
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
2018-12-11
2023-09-30
Active, not recruiting
649
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
2021-09-09
2025-08-01
Recruiting
326
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology
According to Clinical.Site data, the most researched conditions in "AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology" are
"Advanced or Inoperable Gastric Cancer" (1 trials), "Breast Cancer" (1 trials), "Esophageal Squamous Cell Carcinoma (ESCC)" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology" in a lesser frequency.
Clinical Trials Intervention Types at AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology
Most popular intervention types in "AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials), "Elacestrant" (1 trials) and "Fluorouracil (5-FU)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology
The vast majority of trials in "AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology" are
4 trials for "All" genders.
Clinical Trials Status at AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology
Currently, there are NaN active trials in "AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AZ Sint-Jan Brugge - Oostende AV - Campus Sint-Jan - Oncology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".